日本的足部·脚踝用设备市场:各产品，手艺，各用途，各地区，机会，预测，2018年～2032年

2025-2032年预测期内，日本足部和脚踝装置市场规模将以8.55%的复合年增长率增长，从2024年的2.2437亿美元增长到2032年的4.3253亿美元，预计将增长至1000万美元。由于老年人口的增加、微创手术的需求增加以及医疗保健技术的不断进步，预计日本的足部和脚踝设备市场将在预测期内强劲增长。

日本的足部和脚踝装置市场受到糖尿病相关併发症、骨质疏鬆症和运动伤害等疾病高发生率的严重影响。糖尿病週边神经病变影响相当多的人群，併发症可能很严重，并且与严重的足部问题相关，包括显着的截肢率。此外，踝关节疼痛是日本常见的肌肉骨骼压力问题之一，在护理人员等某些职业群体中经常出现。随着人口老化，这种情况推动了对先进骨科解决方案的需求，特别是在城市化和以医疗保健为重点的地区。在日本，膝骨关节炎影响 800 万有症状的人和 2500 万有放射学证据的人，带来了重大的经济和医疗保健课题。到 2050 年，女性平均预期寿命预计将达到 90 岁，男性平均寿命将达到 84 岁，老化将进一步加剧对生活品质和医疗保健系统的影响。

本报告提供日本的足部·脚踝用设备市场相关调查，提供市场概要，以及各产品，手艺，各用途，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 日本的足部·脚踝设备市场预测，2018年～2032年

• 市场规模的分析与预测
• 市场占有率分析与预测
• 市场地图分析，2024年
  • 各产品
  • 手艺
  • 各用途
  • 各地区

第5章 需求供给分析

第6章 价值链分析

第7章 波特的五力分析

第8章 大环境分析

第9章 价格分析

第10章 市场动态

第11章 市场趋势与发展

第12章 法规结构和革新

第13章 专利的形势

第14章 案例研究

第15章 竞争情形

• 市场领导前五名的竞争矩阵
• 参与企业前五名的SWOT分析
• 市场参与企业首位9形势
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Smith & Nephew plc.
  • Acumed LLC
  • DJO Global, Inc. (Enovis)
  • Paragon 28, Incorporated
  • Orthofix Medical Inc

第16章 策略性建议

第17章 咨询方式和免责声明

Japan foot and ankle devices market is projected to witness a CAGR of 8.55% during the forecast period FY2025-FY2032, growing from USD 224.37 million in FY2024 to USD 432.53 million in FY2032. Japan foot and ankle devices market is expected to keep growing robustly during the forecast period owing to an increasing geriatric population, increasing demand for minimally invasive surgery, and increasing advancements in healthcare technology.

The foot and ankle devices market in Japan is largely impacted by high prevalence rates of conditions that include diabetes-related complications, osteoporosis, and sports injuries. Diabetic peripheral neuropathies affect a considerable population, and the complications are likely to become severe and are related to severe foot issues, including having a notable rate of amputations. In addition, foot and ankle pain, which has been frequently reported among specific occupational groups, such as nurses, is one of the broader musculoskeletal stress issues in Japan. With an aging population, these conditions drive demand for advanced orthopedic solutions, especially in urbanized and healthcare-focused regions. In Japan, knee osteoarthritis affects 8 million symptomatic individuals and 25 million with radiographic evidence, creating significant economic and healthcare challenges. With life expectancy projected to reach 90 years for women and 84 years for men by 2050, the aging population exacerbates the impact on quality of life and healthcare systems.

Increasing Prevalence of Foot and Ankle Disorder Boosts Market Growth

The increasing prevalence of foot and ankle disorders is one of the most significant growth drivers in the Japan foot and ankle devices market. Common conditions, such as osteoarthritis, diabetic foot complications, fractures, and ligament injuries, are on the rise due to the increasing prevalence of chronic diseases and an aging population. Demographic changes, along with increasing cases of traumatic incidents, and obesity support the growth of the market. These disorders require specialized medical treatments in the form of implants, external fixation devices, and orthotics and, thus, are developing into an increasing market for advanced treatment solutions. Moreover, patient awareness and availability of orthopedic care are on the rise in urban and semi-urban regions, leading to sustained growth in the market.

For instance, in December 2024, Fujitsu Limited and iSurgery Co. Ltd. launched a bone health promotion project collaborating with Jikei University School of Medicine to improve early osteoporosis detection in Japan. This initiative uses iSurgery's AI-driven bone indicator software to analyze radiographs for bone health, offering a non-invasive method to assess osteoporosis risk.

Rising Awareness and Technological Advancements Drive Market Growth

Growing awareness about foot and ankle health and the pace of technological advancements are major growth drivers for Japan's foot and ankle devices market. Recognition of early diagnosis and treatment methods has driven higher adoption of orthopedic devices, especially in managing osteoarthritis, diabetic foot complications, and sports-related injuries. New technology with applications including 3D-printed implants, biodegradable material, and less invasive surgical techniques help treat patients better. These advancements, supported by growing accessibility to healthcare and initiatives for enhancing podiatric care, support the adoption of advanced devices for feet and ankles in urban and semi-urban regions of Japan.

For instance, in May 2024, OrthAlign, Inc. launched its Lantern handheld technology for knee arthroplasty in Japan, expanding its offerings to total, partial, and revision knee arthroplasty. Lantern provides personalized alignment with single-use, platform-agnostic technology for seamless integration into any operating room. The launch aims to strengthen OrthAlign's market position in Japan and drive growth for its partners.

Soft Tissue Orthopedic Devices Segment to Dominate the Foot and Ankle Devices Market

The soft tissue orthopedic devices segment is expected to capture the maximum market share in the foot and ankle devices market, led by an increasing incidence of sports-related injuries, growth in the prevalence of musculoskeletal disorders, and developments in minimally invasive surgical technologies. Advancements in invasive surgical techniques and the rising adoption of soft tissue repair solutions like tendon and ligament repair products result in improved patient outcomes and shorter recovery times, enhancing the dominance of this product segment. Also, the increasing demand for innovative biologics and synthetic materials to improve repair durability is supposed to boost market growth. For instance, in January 2023, Medacta International SA launched the NextAR Augmented Reality Surgical Platform in Japan. Medacta has successfully performed the first surgeries using its NextAR Augmented Reality Surgical Platform in Japan, following approval from the Ministry of Health, Labour, and Welfare. NextAR offers personalized augmented reality solutions for joint replacement and spine procedures, using real-time patient data to enhance surgical workflows. The platform is designed to improve surgical precision, with applications in knee, shoulder, and spine surgeries.

Osteoporosis Segment is Expected to Dominate the Japan Foot and Ankle Devices Market

The osteoporosis segment dominates the application category in the foot and ankle devices market in Japan because the country has a growing old population, coupled with an increased prevalence of bone diseases. Millions of individuals worldwide suffer from osteoporosis, especially postmenopausal women and geriatric males, which in turn results in an increase in demand for foot and ankle devices to treat fractures, deformities, and loss of bone density. This trend is compounded by the expected increase in the elderly population in Japan, which further increases the demand for sophisticated orthopedic solutions. Advances in implant materials, such as lightweight and biodegradable products, and better fixation techniques are also driving up the use of devices in this segment. The market leaders are now focusing on product development to cater to osteoporosis-related complications and solidify this segment at the top. For instance, in November 2024, Ortho Development Corporation, in partnership with Materialise NV, introduced BKS Total PSI, a patient-specific solution for total knee arthroplasty. This technology combines virtual visualization, pre-operative planning, and 3D-printed guides to enhance surgical precision, improve workflows, and reduce costs in surgical centers and hospitals. Ortho Development focuses on orthopedic solutions in the United States and Japan, with backing from Japan Medical Dynamic Marketing Inc.

Future Market Scenario (FY2025-FY2032F)

Japan is experiencing rapid demographic aging. As a result, orthopedic conditions such as osteoarthritis, fractures, and osteoporosis will highly increase, and thereby, a demand for foot and ankle devices will arise.

Innovations, such as 3D-printed implants, minimally invasive surgical techniques, and advanced fixation devices, will drive growth in the market due to improved efficacy and outcomes.

Rise in awareness about foot and ankle disorders and need for early interventions shall drive adoption of advanced treatment.

Increasing incidences of diabetes and its complications like diabetic foot ulcers will sustain the demand for devices designed particularly to treat these conditions.

Advances in Japan's healthcare facility along with a series of policy changes towards advanced technology medical care shall help accelerate market growth.

Market leaders shall launch innovative products and develop effective partnerships to have a maximum hold on the Japanese market.

A higher prevalence of sports injuries along with musculoskeletal conditions will also push the Japanese market toward upward growth.

Key Players Landscape and Outlook

Japan foot and ankle devices market is being catered to by major key players that have a global presence. Recent market developments include product launches, new treatment center setups, and strategic activities like mergers and acquisitions, driving growth and increasing competition.

For instance, in March 2024, Intellijoint Surgical Inc. received regulatory approval for its Intellijoint KNEE in Japan, marking its second orthopedic product in the country. Intellijoint KNEE provides real-time measurements for surgeons during total knee replacement and is compatible with all implant systems, enhancing its integration into existing surgical workflows and expanding its presence in the computer-assisted surgical navigation market. Following the success of Intellijoint HIP in Japan, the company continues to enhance surgical precision and patient outcomes globally.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Foot and Ankle Devices Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Bracing and Support Devices
    • 4.2.1.2. Joint Implant
    • 4.2.1.3. Orthopedic Fixation
    • 4.2.1.4. Soft Tissue Orthopedic Devices
    • 4.2.1.5. Prosthetics
  • 4.2.2. By Procedure
    • 4.2.2.1. Osteotomy
    • 4.2.2.2. Fracture Repair
    • 4.2.2.3. Fusion Procedures
    • 4.2.2.4. Others
  • 4.2.3. By Application
    • 4.2.3.1. Osteoarthritis
    • 4.2.3.2. Neurological Disorders
    • 4.2.3.3. Trauma
    • 4.2.3.4. Osteoporosis
    • 4.2.3.5. Hammertoe
    • 4.2.3.6. Rheumatoid Arthritis
    • 4.2.3.7. Others
  • 4.2.4. By Region
    • 4.2.4.1. North [Hokkaido and Tohoku]
    • 4.2.4.2. Central [Kanto and Chubu]
    • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Procedure
  • 4.3.3. By Application
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials
• 12.2. Regulatory Approvals
• 12.3. Innovations

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 9 Market Players
  • 15.3.1. Stryker Corporation
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 15.3.2. Zimmer Biomet Holdings, Inc.
  • 15.3.3. Arthrex, Inc.
  • 15.3.4. Johnson & Johnson Services, Inc.
  • 15.3.5. Smith & Nephew plc.
  • 15.3.6. Acumed LLC
  • 15.3.7. DJO Global, Inc. (Enovis)
  • 15.3.8. Paragon 28, Incorporated
  • 15.3.9. Orthofix Medical Inc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Foot and Ankle Devices Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Foot and Ankle Devices Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Foot and Ankle Devices Market Share (%), By Procedure, FY2018-FY2032F
• Figure 4. Japan Foot and Ankle Devices Market Share (%), By Application, FY2018-FY2032F
• Figure 5. Japan Foot and Ankle Devices Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 7. By Procedure Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024